Document is current
Any future updates will be listed below
-
Authors
Stenvall, Anna
Gustafsson, Johan http://orcid.org/0000-0002-1022-8370
Larsson, Erik
Roth, Daniel
Sundlöv, Anna
Jönsson, Lena
Hindorf, Cecilia
Ohlsson, Tomas
Sjögreen Gleisner, Katarina
-
Funding
Funding for this research was provided by:
Cancerfonden (180747, 211754Pj01H)
Fru Berta Kamprads Stiftelse (BKS-2020-13)
Lund University
- License Information
-
More Information
Article History
Received: 5 September 2022
Accepted: 6 December 2022
First Online: 19 December 2022
Declarations
:
: Image data were obtained from two clinical trials, Iluminet (EudraCT No 2011–000240-16, Regionala etikprövningsnämnden Lund, Dnr 2011/287), Gapetto (EudraCT No 2012–004313-13, Regionala etikprövningsnämnden Lund, Dnr 2012/657). Complementary ethics approval was obtained for inclusion of patient data acquired after the closure of Gapetto (Etikprövningsmyndigheten Verksamhetsregion Lund, Dnr 2019–00564). Written informed consent for participation in the studies was obtained from all patients. All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments.
: All patients participating in the trials consented to their anonymized data being published in scientific journals prior to enrolment.
: KSG has participated in research project funded by Fusion Pharmaceuticals Inc, Canada, which does not affect this study. TO has received consultancy fee from Spago Nanomedical AB, Sweden.
